Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapyElectronic supplementary information (ESI) available: Experimental section, Fig. S1-16. See DOI: 10.1039/c8bm00009c

Combinational cancer therapy has been considered as a promising strategy to achieve synergetic therapeutic effects and suppression of multidrug resistance. Herein, we adopted a combination of methotrexate (MTX), an antimetabolite acting on cytoplasm, and 10-hydroxycamptothecin (HCPT), an alkaloid ac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Li, Yang, Zhang, Huabing, Chen, Yilin, Ma, Jinyuan, Lin, Jinyan, Zhang, Yinying, Fan, Zhongxiong, Su, Guanghao, Xie, Liya, Zhu, Xuan, Hou, Zhenqing
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!